
LINK . SPRINGER . COM {
}
Title:
Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas | Virchows Archiv
Description:
The biological significance of the differential expression of cytokeratin (CK) polypeptides in breast carcinomas is unclear. We examined the CK profiles of 101 primary infiltrating ductal breast carcinomas using monoclonal antibodies directed against 11 different CKs and against vimentin. Two major CK phenotypes were distinguished: first, a phenotype expressing only the simple-epithelial CKs 7 (variably), 8, 18 and 19, and secondly, a bimodal phenotype co-expressing significant amounts of one or more of the stratified-epithelial CKs 4, 14 and 17. The vast majority of G1 and G2 carcinomas had the simple-epithelium phenotype, as did a subgroup of G3 carcinomas. Interestingly, the majority (62%) of G3 carcinomas exhibited the bimodal phenotype, with the expression of CKs 4, 14 and 17 being statistically correlated with poor histological differentiation and absence of steroid hormone receptors. The distribution of vimentin only partially overlapped with that of these stratified-epithelial CKs. Prognostic analyses suggested that the presence of CKs 4, 14 and/or 17 was associated with short overall and disease-free survival in subgroups comprising G3, oestrogen-receptor-negative and vimentin-negative tumours. In node-positive tumours the correlation between these CKs and a shorter disease-free interval attained statistical significance (log rank, 0.0096). Thus, abnormal CK profiles in ductal breast carcinomas appear to reflect disturbed regulation of differentiation-related gene expression programmes and may prove to be of clinical value.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Social Networks
- Politics
- Telecommunications
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We find it hard to spot revenue streams.
Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.
Keywords {🔍}
article, breast, carcinomas, cks, privacy, cookies, content, access, information, log, publish, search, prognostic, significance, epithelial, ductal, phenotype, cancer, data, journal, research, virchows, archiv, biological, cytokeratins, infiltrating, august, malzahn, mitze, thoenes, expression, cytokeratin, vimentin, discover, university, germany, springer, optional, personal, parties, policy, find, track, stratified, cite, moll, explore, profiles, primary, bimodal,
Topics {✒️}
month download article/chapter ductal breast carcinomas stratified epithelial cytokeratins disease-free survival privacy choices/manage cookies full article pdf related subjects prognostic analyses suggested breast carcinomas poor histological differentiation vimentin-negative tumours simple-epithelial cks 7 stratified-epithelial cks 4 stratified-epithelial cks virchows archiv 433 g3 carcinomas exhibited european economic area scope submit manuscript monoclonal antibodies directed steroid hormone receptors oestrogen-receptor-negative node-positive tumours reflect disturbed regulation poor patient outcomes johannes gutenberg university martin luther university conditions privacy policy subgroups comprising g3 prognostic significance expressing significant amounts major ck phenotypes simple-epithelium phenotype accepting optional cookies check access instant access abnormal ck profiles journal finder publish article log biological significance august 1998 volume 433 article cite g3 carcinomas article malzahn privacy policy personal data g2 carcinomas books a optional cookies information manage preferences
Schema {🗺️}
WebPage:
mainEntity:
headline:Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas
description: The biological significance of the differential expression of cytokeratin (CK) polypeptides in breast carcinomas is unclear. We examined the CK profiles of 101 primary infiltrating ductal breast carcinomas using monoclonal antibodies directed against 11 different CKs and against vimentin. Two major CK phenotypes were distinguished: first, a phenotype expressing only the simple-epithelial CKs 7 (variably), 8, 18 and 19, and secondly, a bimodal phenotype co-expressing significant amounts of one or more of the stratified-epithelial CKs 4, 14 and 17. The vast majority of G1 and G2 carcinomas had the simple-epithelium phenotype, as did a subgroup of G3 carcinomas. Interestingly, the majority (62%) of G3 carcinomas exhibited the bimodal phenotype, with the expression of CKs 4, 14 and 17 being statistically correlated with poor histological differentiation and absence of steroid hormone receptors. The distribution of vimentin only partially overlapped with that of these stratified-epithelial CKs. Prognostic analyses suggested that the presence of CKs 4, 14 and/or 17 was associated with short overall and disease-free survival in subgroups comprising G3, oestrogen-receptor-negative and vimentin-negative tumours. In node-positive tumours the correlation between these CKs and a shorter disease-free interval attained statistical significance (log rank, 0.0096). Thus, abnormal CK profiles in ductal breast carcinomas appear to reflect disturbed regulation of differentiation-related gene expression programmes and may prove to be of clinical value.
datePublished:
dateModified:
pageStart:119
pageEnd:129
sameAs:https://doi.org/10.1007/s004280050226
keywords:
Key words Intermediate filaments
Cytokeratins
Vimentin
Prognosis
Breast cancer
Pathology
image:
isPartOf:
name:Virchows Archiv
issn:
1432-2307
0945-6317
volumeNumber:433
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:K. Malzahn
affiliation:
name:Institute of Pathology, Johannes Gutenberg University of Mainz, Germany
address:
name:Institute of Pathology, Johannes Gutenberg University of Mainz, Germany, , DE
type:PostalAddress
type:Organization
type:Person
name:M. Mitze
affiliation:
name:Department of Gynaecology, Johannes Gutenberg University of Mainz, Germany
address:
name:Department of Gynaecology, Johannes Gutenberg University of Mainz, Germany, , DE
type:PostalAddress
type:Organization
type:Person
name:M. Thoenes
affiliation:
name:Institute of Pathology, Johannes Gutenberg University of Mainz, Germany
address:
name:Institute of Pathology, Johannes Gutenberg University of Mainz, Germany, , DE
type:PostalAddress
type:Organization
type:Person
name:R. Moll
affiliation:
name:Institute of Pathology, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany
address:
name:Institute of Pathology, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany, , DE
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas
description: The biological significance of the differential expression of cytokeratin (CK) polypeptides in breast carcinomas is unclear. We examined the CK profiles of 101 primary infiltrating ductal breast carcinomas using monoclonal antibodies directed against 11 different CKs and against vimentin. Two major CK phenotypes were distinguished: first, a phenotype expressing only the simple-epithelial CKs 7 (variably), 8, 18 and 19, and secondly, a bimodal phenotype co-expressing significant amounts of one or more of the stratified-epithelial CKs 4, 14 and 17. The vast majority of G1 and G2 carcinomas had the simple-epithelium phenotype, as did a subgroup of G3 carcinomas. Interestingly, the majority (62%) of G3 carcinomas exhibited the bimodal phenotype, with the expression of CKs 4, 14 and 17 being statistically correlated with poor histological differentiation and absence of steroid hormone receptors. The distribution of vimentin only partially overlapped with that of these stratified-epithelial CKs. Prognostic analyses suggested that the presence of CKs 4, 14 and/or 17 was associated with short overall and disease-free survival in subgroups comprising G3, oestrogen-receptor-negative and vimentin-negative tumours. In node-positive tumours the correlation between these CKs and a shorter disease-free interval attained statistical significance (log rank, 0.0096). Thus, abnormal CK profiles in ductal breast carcinomas appear to reflect disturbed regulation of differentiation-related gene expression programmes and may prove to be of clinical value.
datePublished:
dateModified:
pageStart:119
pageEnd:129
sameAs:https://doi.org/10.1007/s004280050226
keywords:
Key words Intermediate filaments
Cytokeratins
Vimentin
Prognosis
Breast cancer
Pathology
image:
isPartOf:
name:Virchows Archiv
issn:
1432-2307
0945-6317
volumeNumber:433
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:K. Malzahn
affiliation:
name:Institute of Pathology, Johannes Gutenberg University of Mainz, Germany
address:
name:Institute of Pathology, Johannes Gutenberg University of Mainz, Germany, , DE
type:PostalAddress
type:Organization
type:Person
name:M. Mitze
affiliation:
name:Department of Gynaecology, Johannes Gutenberg University of Mainz, Germany
address:
name:Department of Gynaecology, Johannes Gutenberg University of Mainz, Germany, , DE
type:PostalAddress
type:Organization
type:Person
name:M. Thoenes
affiliation:
name:Institute of Pathology, Johannes Gutenberg University of Mainz, Germany
address:
name:Institute of Pathology, Johannes Gutenberg University of Mainz, Germany, , DE
type:PostalAddress
type:Organization
type:Person
name:R. Moll
affiliation:
name:Institute of Pathology, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany
address:
name:Institute of Pathology, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany, , DE
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Virchows Archiv
issn:
1432-2307
0945-6317
volumeNumber:433
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Institute of Pathology, Johannes Gutenberg University of Mainz, Germany
address:
name:Institute of Pathology, Johannes Gutenberg University of Mainz, Germany, , DE
type:PostalAddress
name:Department of Gynaecology, Johannes Gutenberg University of Mainz, Germany
address:
name:Department of Gynaecology, Johannes Gutenberg University of Mainz, Germany, , DE
type:PostalAddress
name:Institute of Pathology, Johannes Gutenberg University of Mainz, Germany
address:
name:Institute of Pathology, Johannes Gutenberg University of Mainz, Germany, , DE
type:PostalAddress
name:Institute of Pathology, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany
address:
name:Institute of Pathology, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany, , DE
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:K. Malzahn
affiliation:
name:Institute of Pathology, Johannes Gutenberg University of Mainz, Germany
address:
name:Institute of Pathology, Johannes Gutenberg University of Mainz, Germany, , DE
type:PostalAddress
type:Organization
name:M. Mitze
affiliation:
name:Department of Gynaecology, Johannes Gutenberg University of Mainz, Germany
address:
name:Department of Gynaecology, Johannes Gutenberg University of Mainz, Germany, , DE
type:PostalAddress
type:Organization
name:M. Thoenes
affiliation:
name:Institute of Pathology, Johannes Gutenberg University of Mainz, Germany
address:
name:Institute of Pathology, Johannes Gutenberg University of Mainz, Germany, , DE
type:PostalAddress
type:Organization
name:R. Moll
affiliation:
name:Institute of Pathology, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany
address:
name:Institute of Pathology, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany, , DE
type:PostalAddress
type:Organization
PostalAddress:
name:Institute of Pathology, Johannes Gutenberg University of Mainz, Germany, , DE
name:Department of Gynaecology, Johannes Gutenberg University of Mainz, Germany, , DE
name:Institute of Pathology, Johannes Gutenberg University of Mainz, Germany, , DE
name:Institute of Pathology, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany, , DE
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(31)
- https://www.springernature.com/gp/authors's financial summary
- How much money does https://link.springernature.com/home/ generate?
- https://order.springer.com/public/cart's financial summary
- Find out how much https://www.editorialmanager.com/viar earns monthly
- Check the income stats for https://www.springernature.com/gp/librarians/licensing/agc/journals
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=K.%20Malzahn bring in each month?
- What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22K.%20Malzahn%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M.%20Mitze make?
- Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M.%20Mitze%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M.%20Thoenes generate?
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M.%20Thoenes%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R.%20Moll
- Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R.%20Moll%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the income generated by https://s100.copyright.com/AppDispatchServlet?title=Biological%20and%20prognostic%20significance%20of%20stratified%20epithelial%20cytokeratins%20in%20infiltrating%20ductal%20breast%20carcinomas&author=K.%20Malzahn%20et%20al&contentID=10.1007%2Fs004280050226©right=Springer-Verlag%20Berlin%20Heidelberg&publication=0945-6317&publicationDate=1998-08&publisherName=SpringerNature&orderBeanReset=true each month?
- How much money does https://citation-needed.springer.com/v2/references/10.1007/s004280050226?format=refman&flavour=citation make?
- Get to know what's the income of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
- How much profit does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research generate?
- Get to know what's the income of https://www.springernature.com/gp/products
- What's the revenue for https://www.springernature.com/gp/librarians?
- What's the income of https://www.springernature.com/gp/societies?
- Financial intake of https://www.springernature.com/gp/partners
- Learn about the earnings of https://www.springer.com/
- Explore the financials of https://www.nature.com/
- How much does https://www.biomedcentral.com/ gross monthly?
- What's the total monthly financial gain of https://www.palgrave.com/?
- How much does https://www.apress.com/ earn?
- Explore the financials of https://www.springernature.com/gp/legal/ccpa
- Earnings of https://www.springernature.com/gp/info/accessibility
- What are the total earnings of https://support.springernature.com/en/support/home?
- Monthly income for https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
- Learn how profitable https://www.springernature.com/ is on a monthly basis
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js